Despite additional safeguard measures, performance of Chad’s Global Fund HIV and TB grants are not improving, OIG says
In a report on its audit of Global Fund grants in the Republic of Chad, the Office of the Inspector General (OIG) said that additional safeguard measures have helped “to reduce, but not sufficiently mitigate, significant financial and programmatic risks,” raising questions about the effectiveness of the technical assistance provided by the Gl
On 17 August 2018 and on 26 October 2018, the Global Fund Board approved two HIV grants and three TB grants worth $28.1 million. The Board also approved $15.9 million in matching funds requests for six components.
The Global Fund Board has approved up to $40.5 million for four interim applicant countries: Chad, Papua New Guinea (PNG), Kenya and Mozambique. The Board decisions were based on recommendations from the Grant Approvals Committee (GAC). This brings to five the number of interim applicant countries that have received funding.
The Global Fund last month lifted its temporary suspension of two grants to Chad. The HIV/AIDS and TB grants, worth more than $20 million over five years, were suspended in November 2006 over concerns regarding the misuse of funds and regarding the ability of the Principal Recipient and Sub-Recipients to effectively manage the Global Fund's resources.
The Global Fund has temporarily suspended its two grants to Chad. The Chad CCM has been told to "put in place a new structure" that will ensure effective management of the grants. The two grants - one each to fight HIV/AIDS and TB - have a total five-year value of $21 million, of which $8 million has been disbursed thus far.